Cover Image
市場調查報告書

酒精性肝炎:全球臨床實驗趨勢

Alcoholic Hepatitis Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品編碼 324946
出版日期 內容資訊 英文 66 Pages
訂單完成後即時交付
價格
Back to Top
酒精性肝炎:全球臨床實驗趨勢 Alcoholic Hepatitis Global Clinical Trials Review, H1, 2017
出版日期: 2017年03月31日 內容資訊: 英文 66 Pages
簡介

本報告提供酒精性肝炎相關臨床研究之最新趨勢調查,提供您各地區·進展·階段 (期) ·各募集情況的實驗量,代表性贊助商,開發中治療藥的資訊,並彙整全球各國的主要企業·機關的進展,有潛力的藥劑比較等資訊。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 主要國家的臨床實驗數量:亞太地區
    • 前五名國家的臨床實驗數量:歐洲
    • 主要國家的臨床實驗數量:北美
    • 主要國家的臨床實驗數量:中東/非洲地區

G7各國的臨床實驗數量:酒精性肝炎臨床實驗數量佔消化管疾病臨床實驗數量比率

各期臨床實驗數量:G7各國

G7各國的臨床實驗數量:各期

E7各國的臨床實驗數量:酒精性肝炎臨床實驗數量佔消化管疾病臨床實驗數量比率

各期臨床實驗數量:E7各國

E7各國的臨床實驗數量:各期

各期臨床實驗數量

  • 各期的進展中臨床實驗數量

各進展狀況臨床實驗數量

各評估項目臨床實驗數量

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 酒精性肝炎治療藥

有潛力的藥劑

臨床實驗簡介的基本資料

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's clinical trial report, "Alcoholic Hepatitis Global Clinical Trials Review, H1, 2017" provides an overview of Alcoholic Hepatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Alcoholic Hepatitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Clinical Trials by G7 Countries: Proportion of Alcoholic Hepatitis to Gastrointestinal Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Alcoholic Hepatitis to Gastrointestinal Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials in E7 Countries by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in Alcoholic Hepatitis Therapeutics Clinical Trials 28
  • Prominent Drugs 30
  • Clinical Trial Profile Snapshots 31

Appendix 64

  • Abbreviations 64
  • Definitions 64
  • Research Methodology 65
  • Secondary Research 65
  • About GlobalData 66
  • Contact Us 66
  • Source 66

List of Tables

List of Tables

  • Alcoholic Hepatitis Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Alcoholic Hepatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Alcoholic Hepatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Alcoholic Hepatitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 10
  • Alcoholic Hepatitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
  • Alcoholic Hepatitis Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Alcoholic Hepatitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
  • Proportion of Alcoholic Hepatitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 14
  • Alcoholic Hepatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Alcoholic Hepatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Alcoholic Hepatitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2017* 17
  • Alcoholic Hepatitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
  • Alcoholic Hepatitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Alcoholic Hepatitis Therapeutics, Global, Clinical Trials by Phase, 2017* 20
  • Alcoholic Hepatitis Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 21
  • Alcoholic Hepatitis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
  • Alcoholic Hepatitis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
  • Alcoholic Hepatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
  • Alcoholic Hepatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 25
  • Alcoholic Hepatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
  • Alcoholic Hepatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
  • Alcoholic Hepatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30

List of Figures

List of Figures

  • Alcoholic Hepatitis Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Alcoholic Hepatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Alcoholic Hepatitis Therapeutics, Global, Clinical
Back to Top